ヘルスケア、医薬、医療機器
カテゴリー
日本, アメリカ, ヨーロッパ, その他の国
地理的範囲
ビデオリンク
USD1,000,000.00
販売価格 (USD)
利用できません
通常実施権価格 (USD)
USD500,000.00
専用実施権価格 (USD)
利用できません
通常実施権ロイヤリティレート %
販売、ライセンス種別
パテントファミリー
パテントファミリー数
譲受人 / 権利者
登録日(権利付与済みの場合)
特許公報の公開リンク
追加情報の詳細を見るにはIP Exchange Premiumアカウントにアップグレードする必要があります

SOLIAIR™: New Asthma, Bronchitis, COPD and Respiratory Diseases Natural Drug Discovery!

特許 権利維持 Dear Drug Discovery and Healthcare Investors, <<< >>> I would like to introduce to you my Dietary Supplement for Respiratory and Chronic Lung Diseases (Asthma, COPD, Bronchitis etc.). I believe my product has great potential and a huge market. I would like to explore the possibility of cooperation with you and your company. I am enclosing my presentation and would appreciate your response! <<< >>> SOLIAIR™ Product Overview: <<< >>> SOLIAIR™ is a blend of botanical extracts and a food supplement that contains a unique composition of ingredients, which has reported beneficial impact. SOLIAIR™ can contribute to strengthening the respiratory system and may help patients in chronic respiratory diseases such as Obstructive Lung Disease, Asthma, Bronchitis, COPD (Chronic Obstructive Pulmonary Disease) and other respiratory infections. <<< >>> Patients taking SOLIAIR™ reported a decrease in seasonal infections of the respiratory tract. Reducing the incidence of respiratory infections benefit tremendous potential. The SOLIAIR™ food supplement is free of side effects and has no interaction with conventional medication used for treatment of respiratory disorders! <<< >>> Each SOLIAIR™ food supplement has been authorized and defined by the Israeli Ministry of Health and according to Pharmacists Regulation. The SOLIAIR™ has a patent pending! <<< >>> Market Size Overview: <<< >>> COPD (Chronic Obstructive Pulmonary Disease) and Asthma are Common Diseases and Has No Cure Yet! Respiratory Infections are an important factor and increase the mortality of these diseases. It is estimated that 340 million people worldwide suffer from those diseases. <<< >>> Therapy costs for COPD and its complications totaled in 2006 at $176.8 billion and are expected to rise to $389.2 billion by 2011 and to $832.9 billion by 2021! <<< >>> The SOLIAIR™ Team is Looking for a Person or a Company that: <<< >>> - 1. Handle the Certifications to Sell the Product. - 2. Sell/Market the Product Worldwide. - 3. Direct Sales or Distribution Services Required. <<< >>> Please Contact the SOLIAIR™ Team for More Information: <<< >>> Name: Solomon Jacob (Director/Inventor) e-Mail: solomonj40@gmail.com Company Address: Haifa, 34753 Israel Phone: +972-(0)54-729-5023 Company Presentation: http://goo.gl/6faUeJ <<< >>> Best Regards, SOLIAIR™ Team <<< >>> ** 'Urinary Tract Infections' Natural Therapy Solution Now Available! <<< >>>

$1,000,000 購入 ライセンスを取得 仲介を申し込む 問い合わせ
photo 追加情報の詳細を見るにはIP Exchange PlusまたはIP Exchange Premiumアカウントにアップグレードする必要があります